Unigel Group, intends to join the Aquis Growth Market. Unigel Group is a pioneer in the field of thixotropic gels for the fibre optic cable industry. The Company is also a supplier of laminated steel tapes to the fibre optic cable industry in the US. Thixotropic gels and laminated steel tapes are essential components to the rapidly growing global fibre optic cable market. The Group exports to over 40 countries and is a key supplier to almost every leading fibre optic cable manufacturer worldwide and is the industry’s only organisation with multiple manufacturing facilities spread across 3 continents. The Company acts as the holding company for its wholly-owned operating subsidiary, Unitape Limited and its 60% owned operating subsidiary, Unigel (UK) Limited. Expected 1 August.
Equipmake Holdings intends to join the Aquis Growth Market. Equipmake is a UK-based technology company, which has developed a range of electrification products for the provision of electric vehicle drivetrains to meet the needs of the automotive, aerospace and other sectors in support of the transition from fossil-fuelled to zero emission powertrains. The Company now has a significant pipeline of opportunities of in excess of £400m at various stages of negotiation, as demand for electric vehicles increases as part of the global decarbonisation movement. Expected 29 July.
Georgina Energy, an early-stage resource company with a strategy of actively pursuing the exploration, commercial development and monetisation of helium, hydrogen and hydrocarbon interests located in the Amadeus and Officer Basins in Northern and Western Australia intends to join AIM. Georgina Energy has two principal onshore interests. The first, the Mount Winter Prospect is located in the Amadeus Basin in Northern Australia, which the Company has a right to earn an initial 75% interest. The second interest, the Hussar Prospect is 100% owned by the Company and is located in the Officer Basin in Western Australia. Expected late July.
Macaulay Capital is due to join the Aquis Growth Market on 29 July. The Group was formed to originate and manage corporate transactions, raise funds from third parties, invest the Group’s own funds alongside those of external investors and to manage the Group’s investment portfolio with the aim of maximising its value.
7digital 0.3p £8.2m (7DIG.L)
The B2B end-to-end digital music solutions, announces it has signed a long-term contract with Utopia Music AG, a B2B music fintech company. Utopia is a new customer for the Company. Using 7digital’s global music database capabilities, in addition to Utopia’s existing data capabilities, Utopia’s customers will be able to monitor and measure the consumption of their music copyrights globally. In so doing, Utopia’s customers can leverage data for faster, more accurate payouts of royalties to copyright holders.
Begbies Traynor 143.6p £220.8m (BEG.L)
Begbies Traynor Group announces the acquisition of Axiom Consulting & Investments Limited and Ellayaan Limited and their subsidiary undertakings, which together trade as Mantra Capital, a London-based property finance brokerage. Initial consideration of £4.5m comprised of £4m in cash from the group’s existing facilities and the issue of 352,361 new ordinary shares. As part of the acquisition there is a potential earn out of up to an additional £13.5m (in a mix of cash and shares) subject to delivering material growth in profits over the 4 years post completion. The acquisition is expected to be immediately earnings enhancing and is in line with the strategy to increase the scale, quality and range of the group’s services both organically and through value-accretive acquisitions.
Crimson Tide 2.4p £15.8m (TIDE.L)
The provider of the mpro5 solution, announces a new long-term contract win with a national supplier in the utilities sector. The client will now roll-out the mpro5 solution to digitise processes across its network, covering the North West, Midlands, Yorkshire, the East of England, and North London. The initial term of the agreement is for 3years, with a total value in excess of £1.4m.
Ebiquity 56p £67.3m (EBQ.L)
The media investment analysis company, announces a trading update for the six months ended 30 June 2022, ahead of the interim results announcement planned for 22 September 2022. Revenue growth of approximately £37m, 16% ahead of the same period. Operating profit is expected to be in excess of £4.6m, an increase of at least 100% over the same period last year and underlying operating margin is expected to be at least 12%. The Group’s net debt as at 30 June 2022 was £12.9m. This performance included an initial contribution from Media Management LLC and Media Path, the acquisitions of which were completed in April 2022.
Naked Wines 158p £116.9m (WINE.L)
Naked Wines announces that Shawn Tabak, Chief Financial Officer and Director, has by mutual agreement departed his positions with the company, effective July 22, 2022. James Crawford has been appointed on an interim basis through to June 2023. Mr Crawford previously served as CFO from April 2015 to November 2020. Mr Crawford will combine this interim role with his responsibilities as Managing Director of Naked Wines UK division. The Board position being vacated by Mr. Tabak will not be filled at this time.
Science Group 387p £176.1m (SAG.L)
The science, technology and consulting organisation reports H1 results. For the six months ended 30 June 2022, Group revenue increased by 10% to £44.8m (H1 2021: £40.7m), 7% on a constant currency basis. Adjusted operating profit increased by 22% to £8.8m (H1 2021: £7.3m) and adjusted profit before tax was £8.5m (H1 2021: £6.9m). Adjusted basic earnings per share increased by 10% to 14.6 pence (H1 2021: 13.3 pence). Group cash (excluding client funds) of £38.6m and net funds of £23.9m. The long term debt of £14.7m is secured on the Group’s freehold properties. In addition to the term loan, in December 2021 the Group agreed a £25m revolving credit facility with its bank, which to date has not been drawn. The Group is experiencing increases in materials, energy and staff costs but has to date managed to offset the effects. delivering results slightly ahead of the Board’s expectations.
Thor Mining 0.5p £10.1m (THR.L)
Provide an exploration update on sampling and mapping programs which have been completed at the Company’s 100% owned Ragged Range Project, located in Eastern Pilbara, Western Australia. 3 programs of reconnaissance mapping with rock chip and stream sediment sampling completed over the Ragged Range Project. Rock chip sampling over the 13km-long Sterling Prospect returned up to 6g/t Au in rock chip along newly identified cross structures that strike oblique to the regional faulted contact, Norman Cairn Fault, between the Dalton Suite and Euro Basalts. At the Kelly’s Prospect, anomalous gold (up to 1.46g/t) and copper (4.8% Cu) have been identified along the northwest trending. All samples from the recently completed RC drilling program have now been received by the laboratory, and the Company awaits assay results.
Vast Resources 0.7p £10.3m (VAST.L)
The mining company, announces the Production Report for Q2 2022 from its producing Baita Plai Polymetallic Mine in Romania. Copper concentrate production during Q2 2022 increased 17% from 229 dry metric tonnes in Q1 2022 to 268.8 in Q2 2022. The tonnes milled for the period declined by 6%, however the ore mined increased by 3.5%. The copper grade milled improved by 33% to 0.60% for the period under review. The results are in line with the Company’s expectations. The Company continues to forecast an increase in copper concentrate tonnage produced due to the implementation of the Mantis CMR4 Jumbo Drilling rig. In addition to the increase in copper concentrate produced, an increase in the number of primary metres developed is forecast.
Venture Group 34.5p £43.5m (VLG.L)
The Company which develops, manufactures and commercialises products for the international self-care market, announces a trading update for the six months ended 30 June 2022. The Group expects to release interim results in September. The Company expects to report revenues of £18.9m, a growth of 36% over the same period previous year. This is reflective of the impact of the recent acquisitions of BBI Healthcare Limited and Helsinn Integrative Care Portfolio, contributing revenues of £6.3m. Cash inflow generated from operating activities of £1.5m (H1 2021: £0.7m outflow). Based on trading performance to date and visibility over second half revenue, the Board is confident the Group is on course to deliver full year financial performance in line with market expectations.
Xeros Technology Group 36.5p £8.7m (XSG.L)
The creator of technologies that reduce the impact of clothing on the planet, announces that Neil Austin will be appointed as Chief Executive Officer, effective 1 August 2022. Neil has commercial sales and management experience in the global domestic appliance manufacturing industry, having recently served as Managing Director of Strix (U.K.) Limited. Prior to this position, Neil was Chief Commercial Officer of Neurovalens Limited, and he previously held roles as Sales Director at Glen Dimplex, Consumer Goods division, and as Sales Manager at Whirlpool Corporation.
Disclaimer
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.
